Related Experiment Video
Updated: Oct 12, 2025

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
Antimetastatic defense by CD8+ T cells
Paulino Tallón de Lara1, Héctor Castañón2, Michelle Sterpi1
1Department of Medicine, Mount Sinai West and Mount Sinai Morningside, New York, NY, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
CD8+ T cells eliminate tumor cells and control metastatic spread. This review details how these immune cells combat metastasis at each stage, including dormancy and evolution, with clinical implications.
Area of Science:
- Immunology
- Oncology
- Cancer Metastasis
Background:
- Metastasis is a complex process of tumor cell spread.
- CD8+ T cells are crucial for detecting and eliminating tumor cells.
- Traditionally, research focused on CD8+ T cell roles in primary tumors.
Purpose of the Study:
- To review the mechanisms of CD8+ T cell-mediated control of metastatic lesions.
- To explore the role of CD8+ T cells in each step of the metastatic cascade.
- To discuss the impact on metastatic dormancy, clonal evolution, and clinical outcomes.
Main Methods:
- Literature review of CD8+ T cell functions in metastasis.
- Analysis of mechanisms controlling metastatic spread.
- Synthesis of evidence on antimetastatic immunity.
Main Results:
- CD8+ T cells exhibit unique antimetastatic functions.
- These cells impact multiple stages of the metastatic cascade.
- Their role extends to metastatic dormancy and evolution.
Conclusions:
- CD8+ T cells are critical regulators of metastasis.
- Understanding their mechanisms offers therapeutic potential.
- Targeting CD8+ T cells could improve cancer treatment outcomes.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cell-mediated Immune Responses
Targeted Cancer Therapies
There are several types of targeted therapies against...

